Shu-Chun Chang is an Associate Professor of the Ph.D. Program for Translational Medicine, Taipei Medical University, Taiwan. Dr. Chang trained in extracellular biology and glycobiology and began work on cancer research as her PhD study in Imperial College London (2007-2011). Dr Chang continued to work in the field of Cancer Immunology/Inflammation as her Post-Doc research at the National University of Singapore (2011-2015). Continuing from her postdoctoral research work, her current research focusses on: UPS, cancer therapeutics and anticancer strategies, the tumorigenic microenvironment, Hiltonol cocktails in anti-cancer strategies, anti-PD-L1 cancer vaccine, and BZDR-mediated carcinogenesis.